Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HSPD1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | ZNF571 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ZNF134 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | STK11 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | ABI1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | TEX14 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | SLC35E4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | UBASH3B | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ADAM18 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |